Honasa Consumer Limited (HONASA) stock price moves up 5% intraday to ₹503.95, approaching resistance at ₹508. Backed by Q1 FY27 highest-ever revenue and profit.
Honasa Consumer Limited (HONASA) reports highest-ever quarterly revenue and profit in Q1 FY27, with revenue growing 32% YoY.
Honasa Consumer Limited (NSE: HONASA) stock gains 5% intraday, bouncing from support near ₹439, reflecting a shift in trendline status.
Honasa Consumer Limited (HONASA) acquires 58% in Fluence Pharma, entering nutraceuticals with patented Cyclical Nutrition Therapy.
Honasa Consumer Limited (HONASA) reports 28% YoY growth in Q4 FY26, doubling EBITDA and PAT, marking third consecutive quarter of 20%+ growth.